Cargando…

Evaluation of a semi‐automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers

BACKGROUND: The phenotypic diagnosis of von Willebrand disease (VWD) is a multistep process with classification dependent on the quantification of von Willebrand factor (VWF) multimeric structure. VWF multimer analysis is a technically challenging, lengthy and non‐standardised assay, usually perform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bowyer, Annette E., Goodfellow, Karen J., Seidel, Holger, Westhofen, Philipp, Stufano, Francesca, Goodeve, Anne, Kitchen, Stephen, Makris, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles: Haemostasis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178608/ https://www.ncbi.nlm.nih.gov/pubmed/30349898 http://dx.doi.org/10.1002/rth2.12141

Ejemplares similares

Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use
por: Pikta, Marika, et al.
Publicado: (2021)

Von Willebrand factor multimer quantitation for assessment of cardiac lesion severity and bleeding risk
por: Austin, Christopher O., et al.
Publicado: (2017)

Establishing reference intervals for von Willebrand factor multimers
por: Pikta, Marika, et al.
Publicado: (2022)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
por: Vangenechten, Inge, et al.
Publicado: (2020)

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
por: Skornova, Ingrid, et al.
Publicado: (2021)

Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis
por: Stockschlaeder, Marcus, et al.
Publicado: (2014)

Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study
por: Pagliari, Maria Teresa, et al.
Publicado: (2022)

Control of Von Willebrand Factor Multimer Size by Thrombospondin-1
por: Xie, Lijuan, et al.
Publicado: (2001)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
por: Boender, Johan, et al.
Publicado: (2021)

Structural hierarchy of mechanical extensibility in human von Willebrand factor multimers
por: Csányi, Mária Csilla, et al.
Publicado: (2023)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
por: Gritsch, Herbert, et al.
Publicado: (2022)

Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study
por: Goudemand, Jenny, et al.
Publicado: (2020)

Characterization of Von Willebrand Factor Multimer Structure in Patients With Severe Aortic Stenosis
por: Kellermair, Joerg, et al.
Publicado: (2017)

Advancing multimer analysis of von Willebrand factor by single-molecule AFM imaging
por: Löf, Achim, et al.
Publicado: (2019)

Von Willebrand Factor Multimers and the Relaxation Response: A One-Year Study
por: Dal Lin, Carlo, et al.
Publicado: (2021)

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
por: Deconinck, Shannen, et al.
Publicado: (2018)

Von Willebrand disease type 2M: Correlation between genotype and phenotype
por: Maas, Dominique P. M. S. M., et al.
Publicado: (2021)

Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding
por: Atiq, Ferdows, et al.
Publicado: (2021)

Commonly used anti–von Willebrand factor antibody for multimer analysis cross‐reacts with fibronectin, which is difficult to distinguish from von Willebrand factor
por: Eura, Yuka, et al.
Publicado: (2021)

Inhibition of disulfide bonding of von Willebrand protein by monensin results in small, functionally defective multimers
Publicado: (1985)

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery
por: Peyvandi, F., et al.
Publicado: (2018)

Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age‐related increase of VWF in von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2018)

Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation
por: Palyu, Eszter, et al.
Publicado: (2018)

ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19
por: Pascreau, Tiffany, et al.
Publicado: (2021)

A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura
por: Falter, Tanja, et al.
Publicado: (2023)

Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non‐severe haemophilia A
por: Rejtő, Judit, et al.
Publicado: (2020)

Severe Plasmodium falciparum Malaria Is Associated with Circulating Ultra-Large von Willebrand Multimers and ADAMTS13 Inhibition
por: Larkin, Deirdre, et al.
Publicado: (2009)

One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P(®)/Humate P(®) treatment in von Willebrand disease patients
por: de Jager, Nico C. B., et al.
Publicado: (2019)

Combined effects of two mutations in von Willebrand disease 2M phenotype
por: Woods, Adriana I., et al.
Publicado: (2017)

Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue
por: Casonato, Alessandra, et al.
Publicado: (2017)

Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality
por: Philippe, Aurélien, et al.
Publicado: (2021)

Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients
por: Swinkels, Maurice, et al.
Publicado: (2022)

The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms
por: Sacco, Monica, et al.
Publicado: (2022)

Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assay
por: Riddell, Anne, et al.
Publicado: (2018)

Impact of intraoperative use of venovenous extracorporeal membrane oxygenation on the status of von Willebrand factor large multimers during single lung transplantation
por: Oishi, Hisashi, et al.
Publicado: (2023)

Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement
por: Yamashita, Keigo, et al.
Publicado: (2016)

Cryptic non-canonical splice site activation is part of the mechanism that abolishes multimer organization in the c.2269_2270del von Willebrand factor
por: Daidone, Viviana, et al.
Publicado: (2020)

Letter in response to: circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality
por: Bhogal, P., et al.
Publicado: (2021)

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Acquired von Willebrand syndrome (AVWS) type 2, characterized by decreased high molecular weight multimers, is common in children with severe pulmonary hypertension (PH)
por: Wieland, Ivonne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1gku8hrd1os4j39qj2njk3la95